Comparison of Diagnostic Models to Estimate the Risk of Metabolic Syndrome in a Chilean Pediatric Population: A Cross-Sectional Study.
adipokines
anthropometry
early diagnosis
metabolic biomarkers
metabolic syndrome
pediatric obesity
Journal
Metabolites
ISSN: 2218-1989
Titre abrégé: Metabolites
Pays: Switzerland
ID NLM: 101578790
Informations de publication
Date de publication:
16 Feb 2023
16 Feb 2023
Historique:
received:
22
12
2022
revised:
09
02
2023
accepted:
14
02
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
26
2
2023
Statut:
epublish
Résumé
The pediatric population has various criteria for measuring metabolic syndrome (MetS). The diversity of consensus for diagnosis has led to different non-comparable reported prevalence. Given the increase in its prevalence in pediatric ages, it is necessary to develop efficient methods to encourage early detection. Consequently, early screening for the risk of MetS could favor timely action in preventing associated comorbidities in adulthood. This study aimed to establish the diagnostic capacity of models that use non-invasive (anthropometric) and invasive (serum biomarkers) variables for the early detection of MetS in Chilean children. A cross-sectional study was carried out on 220 children aged 6 to 11. Multivariate logistic regressions and discriminant analyses were applied to determine the diagnostic capacity of invasive and non-invasive variables. Based on these results, four diagnostic models were created and compared: (i) anthropometric, (ii) hormonal (insulin, leptin, and adiponectin), (iii) Lipid A (high-density cholesterol lipoprotein [HDL-c] and triglycerides [TG]) and (iv) Lipid B (TG/HDL-c). The prevalence of MetS was 26.8%. Lipid biomarkers (HDL-c and TG) and their ratio (TG/HDL-c) presented higher diagnostic capacity, above 80%, followed by body mass index (BMI, 0.71-0.88) and waist-to-height ratio (WHtR, 0.70-0.87). The lipid model A was the most accurate (sensitivity [S] = 62.7%, specificity [E] = 96.9%, validity index 87.7%), followed by the anthropometric model (S = 69.5%, E = 88.8% and validity index = 83.6%). In conclusion, detecting MetS was possible through invasive and non-invasive methods tested in overweight and obese children. The proposed models based on anthropometric variables, or serum biomarkers of the lipid model A, presented acceptable validity indices. Moreover, they were higher than those that measured adipokines, leptin, and adiponectin. The anthropometric model was the most cost-effective and easy to apply in different environments.
Identifiants
pubmed: 36837911
pii: metabo13020293
doi: 10.3390/metabo13020293
pmc: PMC9958789
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Cad Saude Publica. 2018 Sep 06;34(9):e00105317
pubmed: 30208174
Pediatr Obes. 2018 Jul;13(7):421-432
pubmed: 29700992
Lipids Health Dis. 2014 Oct 10;13:159
pubmed: 25300321
Adv Exp Med Biol. 2017;960:1-17
pubmed: 28585193
Front Endocrinol (Lausanne). 2019 Aug 16;10:568
pubmed: 31474943
J Clin Res Pediatr Endocrinol. 2019 Sep 25;12(2):180-188
pubmed: 31552725
J Clin Endocrinol Metab. 2004 Jun;89(6):2526-39
pubmed: 15181020
Front Physiol. 2018 Sep 19;9:1238
pubmed: 30333754
Rev Med Chil. 2007 Feb;135(2):174-81
pubmed: 17406734
Transl Pediatr. 2017 Oct;6(4):397-407
pubmed: 29184820
Eur J Med Res. 2010 Nov 4;15 Suppl 2:147-51
pubmed: 21147643
Int J Med Sci. 2016 Jan 01;13(1):25-38
pubmed: 26816492
BMC Pediatr. 2015 Sep 28;15:138
pubmed: 26416207
Nutr Metab Cardiovasc Dis. 2017 Jun;27(6):543-551
pubmed: 28511904
Proc Nutr Soc. 2006 Nov;65(4):385-92
pubmed: 17181905
Arch Endocrinol Metab. 2019 Feb;63(1):30-39
pubmed: 30864629
Keio J Med. 2011;60(1):1-9
pubmed: 21460597
Lipids Health Dis. 2015 Apr 16;14:29
pubmed: 25885289
BMJ. 2009 Feb 23;338:b375
pubmed: 19237405
EJIFCC. 2017 Mar 08;28(1):25-42
pubmed: 28439217
Int J Mol Sci. 2021 Nov 02;22(21):
pubmed: 34769303
Wiad Lek. 2014;67(2 Pt 2):306-10
pubmed: 25796855
Arch Endocrinol Metab. 2017 Jan-Feb;61(1):7-13
pubmed: 27598976
Endocrinol Metab Clin North Am. 2014 Mar;43(1):1-23
pubmed: 24582089
Zhonghua Liu Xing Bing Xue Za Zhi. 2015 Aug;36(8):884-8
pubmed: 26714549
Biomed Res Int. 2017;2017:8728017
pubmed: 29457038
Nutr Hosp. 2013 Nov 01;28(6):1999-2005
pubmed: 24506380
Rev Med Chil. 2011 Jun;139(6):732-8
pubmed: 22051753
J Pediatr Endocrinol Metab. 2020 Jul 28;33(7):821-833
pubmed: 32568734
Rev Med Chil. 2015 Sep;143(9):1136-43
pubmed: 26530196
Public Health Nutr. 2016 Feb;19(3):486-93
pubmed: 25990645
Int J Obes (Lond). 2015 Jul;39(7):1070-8
pubmed: 25869598
Adv Data. 2000 Jun 8;(314):1-27
pubmed: 11183293
Ann Nutr Metab. 2019;75(1):55-65
pubmed: 31117070
Eur J Cardiovasc Nurs. 2016 Dec;15(7):549-558
pubmed: 26743264
Int J Epidemiol. 2019 Oct 1;48(5):1673-1683
pubmed: 31098634
Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S397-S401
pubmed: 28284912
J Paediatr Child Health. 2016 Oct;52(10):928-934
pubmed: 27301065
Rev Med Chil. 2018 Sep;146(9):978-986
pubmed: 30725017
J Obes. 2010;2010:892081
pubmed: 21052532
Metab Syndr Relat Disord. 2013 Apr;11(2):71-80
pubmed: 23249214
Pediatrics. 2017 Aug;140(2):
pubmed: 28739653
Medicina (Kaunas). 2022 Feb 16;58(2):
pubmed: 35208622
BMC Public Health. 2013 Jan 30;13:88
pubmed: 23363707
Ann Hepatol. 2023 Jan-Feb;28(1):100873
pubmed: 36371077
J Pediatr. 2004 Oct;145(4):439-44
pubmed: 15480363
Ann Pediatr Endocrinol Metab. 2019 Sep;24(3):172-179
pubmed: 31607110
Pediatr Int. 2010 Jun;52(3):402-9
pubmed: 19807877
J Pediatr Endocrinol Metab. 2019 Jan 28;32(1):27-31
pubmed: 30530892
Front Genet. 2022 Sep 06;13:961116
pubmed: 36147487
Nutr Metab Cardiovasc Dis. 2019 Nov;29(11):1189-1196
pubmed: 31378631
J Pediatr Endocrinol Metab. 2019 Jan 28;32(1):49-55
pubmed: 30530900
Eur J Pediatr. 2019 Dec;178(12):1813-1822
pubmed: 31522316
BMC Pediatr. 2018 Feb 7;18(1):33
pubmed: 29415673
Med Clin (Barc). 2015 Mar 9;144(5):198-203
pubmed: 24721677
Am J Clin Nutr. 1996 Oct;64(4):650-8
pubmed: 8839517
Arch Pediatr Adolesc Med. 2003 Aug;157(8):821-7
pubmed: 12912790
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Horm Res Paediatr. 2017;88(3-4):181-193
pubmed: 28848168
Int J Obes (Lond). 2014 Sep;38 Suppl 2:S4-14
pubmed: 25376220
Metab Syndr Relat Disord. 2019 May;17(4):210-216
pubmed: 30741590